Kevin Donahoe
Vice President, Head of Diabetes Therapy Area Marketing and Patient Solutions
Bio:
As the VP for the Diabetes TA Marketing Team, Kevin leads a team dedicated to driving change in diabetes with the Ozempic Brand and future launches. Kevin rejoined the marketing team after 3 years as the Area Commercial Lead for The South, where he led over 600 NNI sales employees across 9 states. Prior to leading The South, Kevin was the VP of the Cardiometabolic Portfolio Strategy Team.
Kevin was the original Executive Director of the US Rybelsus Brand Team. The Rybelsus team won the “Drive Change” Award for Q1 2020 for the Launch Training Plan, and Kevin also won Novo Nordisk’s Marketing Manager of the Year Award in 2021.
Kevin joined Novo Nordisk in 2018 after 17 years with Eli Lilly and Company where he led large brands such as Jardiance, Humalog and Cymbalta. Kevin began his career in primary care sales and was promoted to hospital sales where he sold products in the ICU and Cardiac Catheterization lab. Kevin received his BS in Biochemistry from UCLA and earned his MBA from the University of Chicago.
Kevin and his wife Andrea have 5 children: Avery (b. 2007), Keira (b. 2009), Peter (b. 2011), Neely (b. 2013) and Sadie (b. 2020).